Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.
Wherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group.
Wherrett DK, et al. Among authors: orchard tj.
Diabetes Care. 2015 Oct;38(10):1975-85. doi: 10.2337/dc15-1429.
Diabetes Care. 2015.
PMID: 26404927
Free PMC article.
Review.